Primary nonbronchogenic small−cell car− cinoma has been decribed in a number of extrapulmonary sites, including the sali− vary glands, prostate, breast, esophagus, bladder, and cervix [1] . Primary small− cell gastric neuroendocrine carcinomas are extremely rare, representing less than 0.1 % of all primary gastric cancers [2 ± 5] . A 59−year−old woman presented with a 2− month history of intermittent chest pain, nausea, dizziness, diaphoresis, and non− bloody emesis. She had lost 20 lb in weight, but she said that she did not have early satiety or abdominal pain. Her hemoglobin level was 6.1 g/dL, with an iron saturation of 7 %. Computed tomog− raphy did not show any lung or pancreatic masses. Upper endoscopy revealed a 5− cm ulcer with a necrotic base and friable, irregular borders on the lesser curvature of the stomach (l " Figure 1 ). Examination of biopsies of the gastric ulcer showed this to be a high−grade small−cell neu− roendocrine carcinoma (l " Figures 2, 3) . Histologically, the malignant tumor showed solid, organoid, trabecular, and pseudoglandular patterns. The tumor cells showed a high nuclear grade, with minimal cytoplasm, indistinct nucleoli, and nuclear molding, and there was clear evidence of increased mitotic activity and necrosis (l " Figure 3 ). Immunohisto− chemical staining, with adequate con− trols, showed the tumor cells to be strongly positive for pancytokeratin, sy− naptophysin, and CD56 (l " Figures 4 ± 6) , but negative for chromogranin A. Staining for TTF−1, a tissue−specific transcription factor that is specific to thyroid, lung, and brain tissues [3] was negative. This combination of histopathological and im− munohistochemical findings was compa− tible with a high−grade primary small− cell neuroendocrine carcinoma of the stomach. The patient declined further evaluation and management. Gastric neuroendocrine carcinoma is one of the most aggressive cancers, and has an extremely poor prognosis. To date, only 38 cases have been reported (34 of them in Japan) since the first description of the tumor in 1976 [2, 4] . Most cases have been described in male patients. Our patient is an African American wom− an from the United States, which makes this case even more interesting and un− ique. Because of the rarity of these can− cers, the classification and biological characteristics of primary gastric neu− roendocrine carcinomas remain contro− versial, and neuroendocrine differentia− tion is recognized only after appropriate immunohistochemical staining. The lit− erature describes synaptophysin, chro− mogranin A, CD56, and other immunohis− tochemical markers as reliable for detect− ing neuroendocrine differentiation; and the CD56 marker is also being helpful for differentiating between small−cell and large−cell carcinomas [5] . 
